Disease Overview：Osteosarcoma（OS）
Osteosarcoma is a primary malignant bone tumor originating from osteoblast-like cells, most commonly affecting adolescents and young adults during periods of rapid skeletal growth. It typically arises in the metaphyseal region of long bones—especially the distal femur, proximal tibia, and proximal humerus—and exhibits aggressive local invasion with early hematogenous metastasis, predominantly to the lungs. Diagnosis relies on integrated imaging (X-ray, MRI, CT), histopathological examination, and immunohistochemical analysis (e.g., SATB2, RUNX2 positivity). Staging follows the Enneking or AJCC TNM systems, guiding multimodal management: neoadjuvant chemotherapy (typically MAP regimen—methotrexate, doxorubicin, cisplatin), limb-salvage surgery with wide-margin resection and endoprosthetic reconstruction or allograft implantation, followed by adjuvant chemotherapy. Five-year overall survival for localized disease ranges from 60–75% in high-volume centers; outcomes decline significantly with metastatic or poor histologic response.
China offers distinct advantages for osteosarcoma care: leading orthopedic oncology centers—such as Peking University People’s Hospital and Shanghai Jiao Tong University Affiliated Sixth People’s Hospital—combine deep subspecialty expertise with advanced intraoperative navigation, 3D-printed custom prostheses, and real-time margin assessment technologies. Over 1,200 limb-salvage procedures are performed annually across Tier-1 hospitals, with published 5-year survival rates matching or exceeding Western benchmarks. Treatment costs are typically 40–60% lower than in the US or Western Europe, without compromising protocol adherence or supportive care quality. As a dedicated medical tourism agency, we facilitate seamless international patient journeys—vetting accredited hospitals, coordinating multidisciplinary tumor board reviews, providing transparent itemized pricing, arranging visas and accommodation, and offering bilingual clinical liaison and post-treatment follow-up support—all tailored to optimize therapeutic continuity and peace of mind.
Osteosarcoma: treatment in China helps patients compare specialist hospitals, initial assessment steps and estimated costs that may vary by city, institution and clinical condition.
Medical Treatment Guide
Treatment Options & Itemized Cost Breakdown for Osteosarcoma (Orthopedic Oncology)
Non-Surgical / Medical Management
*Indicated for unresectable disease, metastatic burden control, or neoadjuvant/adjuvant chemotherapy.*
- •Neoadjuvant/Adjuvant Chemotherapy (Standard Regimen: MAP—Methotrexate, Doxorubicin, Cisplatin)
- *Cost per Cycle (3–4 cycles pre-op + 4 post-op):* $1,850–$2,600 - IV Methotrexate (high-dose, leucovorin rescue): $420–$610 - IV Doxorubicin: $380–$530 - IV Cisplatin: $290–$410 - Hydration, antiemetics, growth factor support: $760–$1,050
- •Diagnostic & Monitoring Labs/Exams (Per Cycle)
- Serum MTX level (post-high-dose): $110 - Chest CT (baseline + q3mo surveillance): $180 - Whole-body MRI or bone scan (if indicated): $290–$370
Surgical / Procedural Options
*Definitive local control; requires multidisciplinary orthopedic oncology evaluation.*
- •Limb-Salvage Surgery (Endoprosthetic Reconstruction)
- *Procedure Cost (incl. implant, fixation, intraoperative imaging):* $12,400–$18,900 - *Preoperative Workup (mandatory):* - MRI pelvis/limb (tumor staging): $290 - CT angiography (vascular mapping): $220 - Biopsy (CT-guided core): $310
- •Rotationplasty or Amputation
- *Cost (above-knee amputation + prosthetic fitting):* $8,700–$11,300 - *Rotationplasty (including tibial-fibular osteotomy, vascular anastomosis, nerve coaptation):* $14,200–$16,800
Special/Complex Condition Options
- •Metastasectomy (Pulmonary Nodules ≤3, ≤1 cm each)
- Pre-op PET-CT: $480
- •Pathological Fracture Stabilization + Delayed Resection
Quick Selection Guide
- •Adolescent (12–18 y), localized, no comorbidities: Limb-salvage + neoadjuvant MAP ($15,200–$22,500 total)
- •Adult (>60 y), moderate renal impairment, limited budget: Adjuvant MAP only + palliative radiation ($3,200–$4,100)
- •Child <12 y with proximal femoral tumor: Rotationplasty + MAP ($17,800–$21,300)
- •Stage IV (lung mets only, resectable): Neoadjuvant MAP → pulmonary metastasectomy → adjuvant MAP ($22,500–$28,700)
- •Unresectable pelvic tumor: Palliative radiotherapy (30 Gy/10 fx) + systemic therapy ($2,900–$3,800)
Pricing & Service Differences: International / VIP Dept vs. Regular Clinic
International Medical Services (IMS / VIP Departments) at Grade-3A public hospitals and private international clinics operate under self-regulated VIP fee schedules. Fees are higher than standard public clinics (which are subsidized solely for domestic citizens and do not accept overseas insurances). In exchange, international patients receive 6 exclusive medical privileges:
Recommended Hospitals
Explore selected Grade 3A public hospitals in China with rich clinical experience for this condition:
🌴 Recommended Osteosarcoma Medical Vacation Packages
Curated transparent all-inclusive packages combining Osteosarcoma treatment with China top medical destinations:
